nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C19—Prednisone—ankylosing spondylitis	0.0874	0.147	CbGbCtD
Efavirenz—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0859	0.144	CbGbCtD
Efavirenz—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0697	0.117	CbGbCtD
Efavirenz—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0546	0.0915	CbGbCtD
Efavirenz—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0529	0.0887	CbGbCtD
Efavirenz—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0454	0.0761	CbGbCtD
Efavirenz—CYP3A4—Betamethasone—ankylosing spondylitis	0.0453	0.0761	CbGbCtD
Efavirenz—CYP3A4—Prednisolone—ankylosing spondylitis	0.0447	0.0751	CbGbCtD
Efavirenz—CYP3A4—Prednisone—ankylosing spondylitis	0.0423	0.0709	CbGbCtD
Efavirenz—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0415	0.0696	CbGbCtD
Efavirenz—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0264	0.0443	CbGbCtD
Efavirenz—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000423	0.00105	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000423	0.00105	CcSEcCtD
Efavirenz—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00042	0.00104	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—ankylosing spondylitis	0.000419	0.00104	CcSEcCtD
Efavirenz—Angioedema—Dexamethasone—ankylosing spondylitis	0.000418	0.00104	CcSEcCtD
Efavirenz—Angioedema—Betamethasone—ankylosing spondylitis	0.000418	0.00104	CcSEcCtD
Efavirenz—Angiopathy—Prednisone—ankylosing spondylitis	0.000416	0.00103	CcSEcCtD
Efavirenz—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000414	0.00103	CcSEcCtD
Efavirenz—Immune system disorder—Prednisone—ankylosing spondylitis	0.000414	0.00102	CcSEcCtD
Efavirenz—Malaise—Betamethasone—ankylosing spondylitis	0.000413	0.00102	CcSEcCtD
Efavirenz—Malaise—Dexamethasone—ankylosing spondylitis	0.000413	0.00102	CcSEcCtD
Efavirenz—Vertigo—Dexamethasone—ankylosing spondylitis	0.000411	0.00102	CcSEcCtD
Efavirenz—Vertigo—Betamethasone—ankylosing spondylitis	0.000411	0.00102	CcSEcCtD
Efavirenz—Syncope—Dexamethasone—ankylosing spondylitis	0.000411	0.00102	CcSEcCtD
Efavirenz—Syncope—Betamethasone—ankylosing spondylitis	0.000411	0.00102	CcSEcCtD
Efavirenz—Arrhythmia—Prednisone—ankylosing spondylitis	0.000409	0.00101	CcSEcCtD
Efavirenz—Sweating—Methotrexate—ankylosing spondylitis	0.000409	0.00101	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—ankylosing spondylitis	0.000407	0.00101	CcSEcCtD
Efavirenz—Shock—Triamcinolone—ankylosing spondylitis	0.000405	0.001	CcSEcCtD
Efavirenz—Insomnia—Prednisolone—ankylosing spondylitis	0.000405	0.001	CcSEcCtD
Efavirenz—Alopecia—Prednisone—ankylosing spondylitis	0.000405	0.001	CcSEcCtD
Efavirenz—Shock—Methylprednisolone—ankylosing spondylitis	0.000404	0.001	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000403	0.000998	CcSEcCtD
Efavirenz—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000403	0.000997	CcSEcCtD
Efavirenz—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000402	0.000996	CcSEcCtD
Efavirenz—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000402	0.000996	CcSEcCtD
Efavirenz—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000402	0.000995	CcSEcCtD
Efavirenz—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000402	0.000995	CcSEcCtD
Efavirenz—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000401	0.000993	CcSEcCtD
Efavirenz—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000399	0.000988	CcSEcCtD
Efavirenz—Erythema—Prednisone—ankylosing spondylitis	0.000399	0.000987	CcSEcCtD
Efavirenz—Malnutrition—Prednisone—ankylosing spondylitis	0.000399	0.000987	CcSEcCtD
Efavirenz—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000398	0.000985	CcSEcCtD
Efavirenz—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000397	0.000983	CcSEcCtD
Efavirenz—Convulsion—Dexamethasone—ankylosing spondylitis	0.000397	0.000982	CcSEcCtD
Efavirenz—Convulsion—Betamethasone—ankylosing spondylitis	0.000397	0.000982	CcSEcCtD
Efavirenz—Hypertension—Betamethasone—ankylosing spondylitis	0.000395	0.000978	CcSEcCtD
Efavirenz—Hypertension—Dexamethasone—ankylosing spondylitis	0.000395	0.000978	CcSEcCtD
Efavirenz—Myalgia—Dexamethasone—ankylosing spondylitis	0.00039	0.000965	CcSEcCtD
Efavirenz—Myalgia—Betamethasone—ankylosing spondylitis	0.00039	0.000965	CcSEcCtD
Efavirenz—Anxiety—Dexamethasone—ankylosing spondylitis	0.000388	0.000961	CcSEcCtD
Efavirenz—Anxiety—Betamethasone—ankylosing spondylitis	0.000388	0.000961	CcSEcCtD
Efavirenz—Discomfort—Dexamethasone—ankylosing spondylitis	0.000385	0.000953	CcSEcCtD
Efavirenz—Discomfort—Betamethasone—ankylosing spondylitis	0.000385	0.000953	CcSEcCtD
Efavirenz—Pain—Prednisolone—ankylosing spondylitis	0.000383	0.000948	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—ankylosing spondylitis	0.000383	0.000947	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000378	0.000936	CcSEcCtD
Efavirenz—Vision blurred—Prednisone—ankylosing spondylitis	0.000376	0.00093	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000375	0.000929	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000375	0.000929	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000374	0.000927	CcSEcCtD
Efavirenz—Insomnia—Triamcinolone—ankylosing spondylitis	0.000372	0.000922	CcSEcCtD
Efavirenz—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000372	0.00092	CcSEcCtD
Efavirenz—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00037	0.000916	CcSEcCtD
Efavirenz—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00037	0.000915	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000369	0.000913	CcSEcCtD
Efavirenz—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000369	0.000913	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—ankylosing spondylitis	0.000369	0.000913	CcSEcCtD
Efavirenz—Anaemia—Prednisone—ankylosing spondylitis	0.000368	0.000912	CcSEcCtD
Efavirenz—Shock—Betamethasone—ankylosing spondylitis	0.000368	0.00091	CcSEcCtD
Efavirenz—Shock—Dexamethasone—ankylosing spondylitis	0.000368	0.00091	CcSEcCtD
Efavirenz—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000367	0.000909	CcSEcCtD
Efavirenz—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000366	0.000907	CcSEcCtD
Efavirenz—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000366	0.000907	CcSEcCtD
Efavirenz—Agitation—Prednisone—ankylosing spondylitis	0.000366	0.000907	CcSEcCtD
Efavirenz—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000366	0.000905	CcSEcCtD
Efavirenz—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000366	0.000905	CcSEcCtD
Efavirenz—Tachycardia—Betamethasone—ankylosing spondylitis	0.000365	0.000903	CcSEcCtD
Efavirenz—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000365	0.000903	CcSEcCtD
Efavirenz—Angioedema—Prednisone—ankylosing spondylitis	0.000364	0.000902	CcSEcCtD
Efavirenz—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000362	0.000897	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000362	0.000896	CcSEcCtD
Efavirenz—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000362	0.000895	CcSEcCtD
Efavirenz—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000361	0.000894	CcSEcCtD
Efavirenz—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000361	0.000894	CcSEcCtD
Efavirenz—Malaise—Prednisone—ankylosing spondylitis	0.00036	0.00089	CcSEcCtD
Efavirenz—Vertigo—Prednisone—ankylosing spondylitis	0.000358	0.000887	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—ankylosing spondylitis	0.000358	0.000885	CcSEcCtD
Efavirenz—Syncope—Prednisone—ankylosing spondylitis	0.000358	0.000885	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—ankylosing spondylitis	0.000357	0.000883	CcSEcCtD
Efavirenz—Anorexia—Betamethasone—ankylosing spondylitis	0.000356	0.000882	CcSEcCtD
Efavirenz—Anorexia—Dexamethasone—ankylosing spondylitis	0.000356	0.000882	CcSEcCtD
Efavirenz—Urticaria—Prednisolone—ankylosing spondylitis	0.000356	0.00088	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000355	0.000879	CcSEcCtD
Efavirenz—Fatigue—Triamcinolone—ankylosing spondylitis	0.000355	0.000879	CcSEcCtD
Efavirenz—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000354	0.000877	CcSEcCtD
Efavirenz—Pain—Triamcinolone—ankylosing spondylitis	0.000352	0.000872	CcSEcCtD
Efavirenz—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00035	0.000867	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—ankylosing spondylitis	0.000347	0.00086	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000346	0.000856	CcSEcCtD
Efavirenz—Convulsion—Prednisone—ankylosing spondylitis	0.000345	0.000855	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000345	0.000854	CcSEcCtD
Efavirenz—Hypertension—Prednisone—ankylosing spondylitis	0.000344	0.000852	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00034	0.000843	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00034	0.000843	CcSEcCtD
Efavirenz—Arthralgia—Prednisone—ankylosing spondylitis	0.000339	0.00084	CcSEcCtD
Efavirenz—Myalgia—Prednisone—ankylosing spondylitis	0.000339	0.00084	CcSEcCtD
Efavirenz—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000339	0.00084	CcSEcCtD
Efavirenz—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000339	0.000838	CcSEcCtD
Efavirenz—Anxiety—Prednisone—ankylosing spondylitis	0.000338	0.000837	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—ankylosing spondylitis	0.000338	0.000837	CcSEcCtD
Efavirenz—Insomnia—Dexamethasone—ankylosing spondylitis	0.000338	0.000836	CcSEcCtD
Efavirenz—Insomnia—Betamethasone—ankylosing spondylitis	0.000338	0.000836	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000337	0.000834	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000336	0.000832	CcSEcCtD
Efavirenz—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000335	0.00083	CcSEcCtD
Efavirenz—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000335	0.00083	CcSEcCtD
Efavirenz—Discomfort—Prednisone—ankylosing spondylitis	0.000335	0.00083	CcSEcCtD
Efavirenz—Erythema—Methotrexate—ankylosing spondylitis	0.000333	0.000825	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—ankylosing spondylitis	0.000333	0.000825	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00033	0.000817	CcSEcCtD
Efavirenz—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000329	0.000814	CcSEcCtD
Efavirenz—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000329	0.000814	CcSEcCtD
Efavirenz—Urticaria—Triamcinolone—ankylosing spondylitis	0.000327	0.00081	CcSEcCtD
Efavirenz—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000326	0.000808	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000326	0.000808	CcSEcCtD
Efavirenz—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000326	0.000806	CcSEcCtD
Efavirenz—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000325	0.000804	CcSEcCtD
Efavirenz—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000325	0.000804	CcSEcCtD
Efavirenz—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000325	0.000804	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000323	0.000798	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000323	0.000798	CcSEcCtD
Efavirenz—Back pain—Methotrexate—ankylosing spondylitis	0.000322	0.000798	CcSEcCtD
Efavirenz—Fatigue—Betamethasone—ankylosing spondylitis	0.000322	0.000797	CcSEcCtD
Efavirenz—Fatigue—Dexamethasone—ankylosing spondylitis	0.000322	0.000797	CcSEcCtD
Efavirenz—Shock—Prednisone—ankylosing spondylitis	0.00032	0.000792	CcSEcCtD
Efavirenz—Pain—Dexamethasone—ankylosing spondylitis	0.000319	0.000791	CcSEcCtD
Efavirenz—Pain—Betamethasone—ankylosing spondylitis	0.000319	0.000791	CcSEcCtD
Efavirenz—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000319	0.00079	CcSEcCtD
Efavirenz—Tachycardia—Prednisone—ankylosing spondylitis	0.000318	0.000786	CcSEcCtD
Efavirenz—Skin disorder—Prednisone—ankylosing spondylitis	0.000316	0.000782	CcSEcCtD
Efavirenz—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000315	0.000779	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—ankylosing spondylitis	0.000314	0.000777	CcSEcCtD
Efavirenz—Anorexia—Prednisone—ankylosing spondylitis	0.00031	0.000768	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000309	0.000765	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—ankylosing spondylitis	0.000308	0.000762	CcSEcCtD
Efavirenz—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000308	0.000762	CcSEcCtD
Efavirenz—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000308	0.000762	CcSEcCtD
Efavirenz—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000306	0.000756	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000306	0.000756	CcSEcCtD
Efavirenz—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000303	0.000751	CcSEcCtD
Efavirenz—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000303	0.000749	CcSEcCtD
Efavirenz—Malaise—Methotrexate—ankylosing spondylitis	0.0003	0.000744	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—ankylosing spondylitis	0.000299	0.000741	CcSEcCtD
Efavirenz—Urticaria—Dexamethasone—ankylosing spondylitis	0.000297	0.000735	CcSEcCtD
Efavirenz—Urticaria—Betamethasone—ankylosing spondylitis	0.000297	0.000735	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000296	0.000734	CcSEcCtD
Efavirenz—Dizziness—Prednisolone—ankylosing spondylitis	0.000296	0.000733	CcSEcCtD
Efavirenz—Asthenia—Triamcinolone—ankylosing spondylitis	0.000295	0.000731	CcSEcCtD
Efavirenz—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000295	0.000731	CcSEcCtD
Efavirenz—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000295	0.000731	CcSEcCtD
Efavirenz—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000295	0.000731	CcSEcCtD
Efavirenz—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000295	0.000731	CcSEcCtD
Efavirenz—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000295	0.00073	CcSEcCtD
Efavirenz—Insomnia—Prednisone—ankylosing spondylitis	0.000294	0.000728	CcSEcCtD
Efavirenz—Paraesthesia—Prednisone—ankylosing spondylitis	0.000292	0.000723	CcSEcCtD
Efavirenz—Pruritus—Triamcinolone—ankylosing spondylitis	0.000291	0.000721	CcSEcCtD
Efavirenz—Cough—Methotrexate—ankylosing spondylitis	0.000291	0.00072	CcSEcCtD
Efavirenz—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000291	0.000719	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—ankylosing spondylitis	0.000289	0.000715	CcSEcCtD
Efavirenz—Dyspepsia—Prednisone—ankylosing spondylitis	0.000286	0.000709	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—ankylosing spondylitis	0.000284	0.000702	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—ankylosing spondylitis	0.000284	0.000702	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—ankylosing spondylitis	0.000284	0.000702	CcSEcCtD
Efavirenz—Decreased appetite—Prednisone—ankylosing spondylitis	0.000283	0.0007	CcSEcCtD
Efavirenz—Rash—Prednisolone—ankylosing spondylitis	0.000282	0.000699	CcSEcCtD
Efavirenz—Dermatitis—Prednisolone—ankylosing spondylitis	0.000282	0.000698	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000282	0.000697	CcSEcCtD
Efavirenz—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000281	0.000696	CcSEcCtD
Efavirenz—Fatigue—Prednisone—ankylosing spondylitis	0.000281	0.000694	CcSEcCtD
Efavirenz—Headache—Prednisolone—ankylosing spondylitis	0.000281	0.000694	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—ankylosing spondylitis	0.00028	0.000694	CcSEcCtD
Efavirenz—Constipation—Prednisone—ankylosing spondylitis	0.000278	0.000689	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—ankylosing spondylitis	0.000274	0.000679	CcSEcCtD
Efavirenz—Dizziness—Triamcinolone—ankylosing spondylitis	0.000272	0.000674	CcSEcCtD
Efavirenz—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000272	0.000672	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000268	0.000664	CcSEcCtD
Efavirenz—Asthenia—Betamethasone—ankylosing spondylitis	0.000268	0.000664	CcSEcCtD
Efavirenz—Asthenia—Dexamethasone—ankylosing spondylitis	0.000268	0.000664	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000267	0.00066	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000266	0.000659	CcSEcCtD
Efavirenz—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000266	0.000659	CcSEcCtD
Efavirenz—Nausea—Prednisolone—ankylosing spondylitis	0.000266	0.000658	CcSEcCtD
Efavirenz—Pruritus—Dexamethasone—ankylosing spondylitis	0.000264	0.000654	CcSEcCtD
Efavirenz—Pruritus—Betamethasone—ankylosing spondylitis	0.000264	0.000654	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—ankylosing spondylitis	0.000264	0.000654	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000263	0.000651	CcSEcCtD
Efavirenz—Vomiting—Triamcinolone—ankylosing spondylitis	0.000262	0.000648	CcSEcCtD
Efavirenz—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000261	0.000647	CcSEcCtD
Efavirenz—Rash—Triamcinolone—ankylosing spondylitis	0.00026	0.000643	CcSEcCtD
Efavirenz—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000259	0.000642	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—ankylosing spondylitis	0.000259	0.000642	CcSEcCtD
Efavirenz—Rash—Methylprednisolone—ankylosing spondylitis	0.000259	0.000641	CcSEcCtD
Efavirenz—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000259	0.000641	CcSEcCtD
Efavirenz—Urticaria—Prednisone—ankylosing spondylitis	0.000258	0.00064	CcSEcCtD
Efavirenz—Headache—Triamcinolone—ankylosing spondylitis	0.000258	0.000638	CcSEcCtD
Efavirenz—Headache—Methylprednisolone—ankylosing spondylitis	0.000257	0.000637	CcSEcCtD
Efavirenz—Body temperature increased—Prednisone—ankylosing spondylitis	0.000257	0.000637	CcSEcCtD
Efavirenz—Abdominal pain—Prednisone—ankylosing spondylitis	0.000257	0.000637	CcSEcCtD
Efavirenz—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000256	0.000633	CcSEcCtD
Efavirenz—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000256	0.000633	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000248	0.000613	CcSEcCtD
Efavirenz—Dizziness—Dexamethasone—ankylosing spondylitis	0.000247	0.000612	CcSEcCtD
Efavirenz—Dizziness—Betamethasone—ankylosing spondylitis	0.000247	0.000612	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—ankylosing spondylitis	0.000246	0.000609	CcSEcCtD
Efavirenz—Nausea—Triamcinolone—ankylosing spondylitis	0.000245	0.000605	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000244	0.000604	CcSEcCtD
Efavirenz—Nausea—Methylprednisolone—ankylosing spondylitis	0.000244	0.000604	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000242	0.0006	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—ankylosing spondylitis	0.000242	0.000598	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00024	0.000593	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000239	0.000592	CcSEcCtD
Efavirenz—Vomiting—Dexamethasone—ankylosing spondylitis	0.000238	0.000588	CcSEcCtD
Efavirenz—Vomiting—Betamethasone—ankylosing spondylitis	0.000238	0.000588	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000236	0.000585	CcSEcCtD
Efavirenz—Rash—Betamethasone—ankylosing spondylitis	0.000236	0.000583	CcSEcCtD
Efavirenz—Rash—Dexamethasone—ankylosing spondylitis	0.000236	0.000583	CcSEcCtD
Efavirenz—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000235	0.000583	CcSEcCtD
Efavirenz—Dermatitis—Betamethasone—ankylosing spondylitis	0.000235	0.000583	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000235	0.000581	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—ankylosing spondylitis	0.000234	0.00058	CcSEcCtD
Efavirenz—Headache—Betamethasone—ankylosing spondylitis	0.000234	0.000579	CcSEcCtD
Efavirenz—Headache—Dexamethasone—ankylosing spondylitis	0.000234	0.000579	CcSEcCtD
Efavirenz—Asthenia—Prednisone—ankylosing spondylitis	0.000233	0.000578	CcSEcCtD
Efavirenz—Pain—Methotrexate—ankylosing spondylitis	0.000233	0.000576	CcSEcCtD
Efavirenz—Pruritus—Prednisone—ankylosing spondylitis	0.00023	0.00057	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000224	0.000555	CcSEcCtD
Efavirenz—Diarrhoea—Prednisone—ankylosing spondylitis	0.000223	0.000551	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000222	0.00055	CcSEcCtD
Efavirenz—Nausea—Betamethasone—ankylosing spondylitis	0.000222	0.000549	CcSEcCtD
Efavirenz—Nausea—Dexamethasone—ankylosing spondylitis	0.000222	0.000549	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—ankylosing spondylitis	0.000216	0.000535	CcSEcCtD
Efavirenz—Dizziness—Prednisone—ankylosing spondylitis	0.000215	0.000533	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000215	0.000532	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000215	0.000532	CcSEcCtD
Efavirenz—Vomiting—Prednisone—ankylosing spondylitis	0.000207	0.000512	CcSEcCtD
Efavirenz—Rash—Prednisone—ankylosing spondylitis	0.000205	0.000508	CcSEcCtD
Efavirenz—Dermatitis—Prednisone—ankylosing spondylitis	0.000205	0.000507	CcSEcCtD
Efavirenz—Headache—Prednisone—ankylosing spondylitis	0.000204	0.000505	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.0002	0.000496	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—ankylosing spondylitis	0.000195	0.000483	CcSEcCtD
Efavirenz—Nausea—Prednisone—ankylosing spondylitis	0.000193	0.000478	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—ankylosing spondylitis	0.000192	0.000476	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000186	0.000461	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—ankylosing spondylitis	0.00018	0.000445	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—ankylosing spondylitis	0.000173	0.000428	CcSEcCtD
Efavirenz—Rash—Methotrexate—ankylosing spondylitis	0.000171	0.000424	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—ankylosing spondylitis	0.000171	0.000424	CcSEcCtD
Efavirenz—Headache—Methotrexate—ankylosing spondylitis	0.00017	0.000422	CcSEcCtD
Efavirenz—Nausea—Methotrexate—ankylosing spondylitis	0.000162	0.0004	CcSEcCtD
